Lab test could match cancer patients to the right drugs
NCT ID NCT07468422
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new lab method called OPTin that helps doctors pick the most effective drugs for people with advanced or hard-to-treat solid tumors. About 200 adults will provide a small tumor sample for testing, then receive either a drug chosen by OPTin or one selected by their doctor. The goal is to see if OPTin-guided therapy improves tumor shrinkage and overall health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER (ADVANCED STAGE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China medical university hospital
Taichung, 40401, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New radiation method targets tough tumors
- New support program aims to ease emotional burden of advanced cancer
- Fasting during immunotherapy: a new way to boost treatment?
- Is a 1930s law blocking safe cancer info online? new survey investigates
- New survey aims to capture what really matters to cancer patients